Stepwise integration of the IPA beneficiaries in the activities of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the Reitox network
July 1, 2017 - June 30, 2019
Funded by IPA 2016, the overall objective is to ensure that IPA II beneficiaries are able to participate effectively in the activities of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the Reitox network upon accession.
The specific objective of the project is to support the approximation to and adoption of the EU acquis in the IPA II beneficiaries in the area of Rule of Law and in particular in the drug information field.
The project is structured around five expected outputs which are:
Op1: a strengthened coordination body at national level–National Drug Observatory (NDO)
Op2: an updated or new data sets and reports on drug related issues
Op3: a strengthened national Early Warning System (EWS)
Op4: an improved communication and visibility of the project
Op5: an on–going inter–institutional coordination
For more information please visit the project website here.